Dr Karina Apricó
2002 - PhD Pharmacology, Monash University, Australia
1998 - BSc (Hons) Pharmacology, Monash University, Australia
1987 - BSc Pharmacology & Physiology, Monash University, Australia
オーストラリア在住。博士論文「"[3H]4-methylglutamate as a novel radioligand for the brain glutamate transporters」。2005年までArvid Carlsson 研究所（スウェーデン、イェーテボリ）にて反応性アストログリオーシスの生体外モデルについてMichael Nilsson博士と共同研究し、博士課程修了。以降は薬物学と生理学の大学講師を務める。
Dr Aprico's doctoral thesis was "[3H]4-methylglutamate as a novel radioligand for the brain glutamate transporters." From 2003 to 2005, Dr Aprico held a post-doctoral position at Arvid Carlsson Institute, Göteborg, Sweden, working with Dr Michael Nilsson, investigating in vitro models of reactive astrogliosis. Since 2005, Dr Aprico has been a university lecturer in pharmacology and physiology, but returned to university to obtain her medical degree in mid-2009. Dr Aprico began as an editor with the Edanz Group in 2008.
